- Investing Ideas
- U.K. Pharmaceuticals & Biotech Leverage Leaders
U.K. Pharmaceuticals & Biotech Leverage Leaders
Results
2
1 new
2 companies
Genus
Market Cap: UK£1.5b
Produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia.
GNS
UK£22.98
7D
1.1%
1Y
-14.1%
Oxford Nanopore Technologies
Market Cap: UK£1.8b
Engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows analysis of DNA or RNA.
New
ONT
UK£1.83
7D
49.8%
1Y
-8.4%